This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignees: Xiamen Innodx Biotech Co., Ltd., Xiamen University. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 2 
1 out of 165 Years Active: 2023
Title: **Shunhua Wen: Innovator in HBsAg Detection Methods**
Introduction
Shunhua Wen is a notable inventor based in Xiamen, China, recognized for his contributions to the field of medical diagnostics. With a focus on innovative detection methods, he has successfully developed technologies that enhance the accuracy and efficiency of HBsAg testing. His work is pivotal in the context of public health, especially in diagnosing viral infections.
Latest Patents
Shunhua Wen holds a patent for a groundbreaking kit and method aimed at the quantitative detection of HBsAg. This patent encompasses a kit designed to measure HBsAg levels in samples, which is critical for assessing Hepatitis B virus infections. The innovative kit includes a first antibody that specifically binds to HBsAg and integrates a reagent composition comprising tris(2-carboxyethyl)phosphine hydrochloride (TCEP) and urea. This development significantly improves the quantitative detection capabilities essential for medical testing.
Career Highlights
Throughout his career, Shunhua Wen has been associated with leading organizations such as Xiamen Innodx Biotech Co., Ltd. and Xiamen University. His tenure at these institutions has provided him with the platform to translate his innovative ideas into practical applications, thereby advancing the field of biotechnology and diagnostics.
Collaborations
In his professional journey, Shunhua Wen has collaborated with distinguished colleagues, including Liuwei Song and Zuxing Weng. These partnerships have enriched his research endeavors and have facilitated the development of effective diagnostic tools that are accessible for medical use.
Conclusion
Shunhua Wen exemplifies the spirit of innovation in the biomedical sector. His patent for the detection of HBsAg not only highlights his inventiveness but also signifies a major step forward in the diagnostics field. As he continues to work alongside renowned experts and institutions, his future contributions are anticipated to bring further advancements in healthcare technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile